ABSCINT
Biotech / Medtech / Start-up
Liège, BelgiumAbout
ABSCINT is a Belgian biotechnology spin-off (founded in 2020) headquartered in Liège, specialising in cutting-edge molecular imaging diagnostics.
Core Technology & Mission
The company develops in vivo PET (Positron Emission Tomography) tracers using radio‑labeled single‑domain antibodies (sdAbs).
These sdAb tracers enable:
-
Highly specific, rapid whole‑body imaging of molecular targets (e.g., HER2)
-
Fast results—full-body scans within 60–90 minutes post-injection
-
Minimal radiation dose and no need for patient hospitalization due to quick tracer clearance .
Their stated mission is to transform HER2‑related cancer care by accelerating the diagnostic journey and enabling personalized treatment decisions
HEALTH SECTOR
CLINICAL DEVELOPMENT AND TRIALS
THERAPEUTIC AREAS
RESEARCH AND DEVELOPMENT
Representatives
CEO
ABSCINT